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Insights Into the Pathophysiology of Cellulite: A Review
Lawrence S. Bass, MD*† and Michael S. Kaminer, MD‡xk

BACKGROUND The etiology of cellulite is unclear. Treatment of cellulite has targeted adipose tissue, dermis,
and fibrous septae with varying degrees of success and durability of response.
OBJECTIVE Results from clinical trials that target different anatomical aspects of cellulite can provide
insights into the underlying pathophysiology of cellulite.
MATERIALS AND METHODS A search of the PubMed database and ClinicalTrials.gov website was conducted
to identify clinical trials that have investigated treatments for cellulite.
RESULTS A lack of trial protocol standardization, objective means for quantification of improvement and
reported cellulite severity, and short-term follow-up, as well as variation in assessment methods have made
comparisons among efficacy studies challenging. However, the lack of durable efficacy and inconsistency seen
in clinical results suggest that dermal or adipose tissue changes are not the primary etiologies of cellulite.
Clinical studies targeting the collagen-rich fibrous septae in cellulite dimples through mechanical, surgical, or
enzymatic approaches suggest that targeting fibrous septae is the strategy most likely to provide durable
improvement of skin topography and the appearance of cellulite.
CONCLUSION The etiology of cellulite has not been completely elucidated. However, there is compelling
clinical evidence that fibrous septae play a central role in the pathophysiology of cellulite.
M.S. Kaminer reports serving as a clinical investigator and consultant for Endo Pharmaceuticals Inc. and
serving as a consultant for Arctic Fox LLC, ExploraMed, and Soliton, Inc. Technical editorial and medical
writing assistance was provided, under the direction of the authors, by Mary Beth Moncrief and Julie B.
Stimmel, Synchrony Medical Communications, LLC, West Chester, PA. Funding for this support was provided
by Endo Pharmaceuticals Inc., Malvern, PA. Endo Pharmaceuticals did not actively contribute to the article
content or interpretation, reviewed for scientific accuracy only, and had no role in the decision to submit the
article for publication. L.S. Bass reports being an advisory board participant for Endo Pharmaceuticals Inc.;
serving as a consultant for Cynosure, A Hologic Company; and being a clinical investigator for Cynosure, A
Hologic Company, Endo Pharmaceuticals Inc., and Merz North America.

C

ellulite is described as an aesthetic alteration of
the skin surface characterized by a padded
“orange peel” dimpling of the skin.1–3 Although
robust epidemiologic data are lacking in the scientiﬁc
literature, cellulite is estimated to occur in 80% to
98% of postpubertal women.3,4 In healthy men,

cellulite is rare, but it can occur because of medical
conditions that result in androgen deﬁciency or require
estrogen therapy.1,4 It has been difﬁcult to achieve
durable success with treatments for cellulite, including
topical agents, energy-based devices, subcision, and
injectable biologic agents, all of which target key
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tissues (i.e., dermis, adipose, ﬁbrous septae, or a
combination of these).5 However, data from
anatomical studies have increased our understanding
of the underlying physiology of cellulite.1,6–8
Integrating this anatomical information with data
from clinical studies examining speciﬁc tissues
involved in cellulite may increase our knowledge of
cellulite etiology and lead to improved cellulite
treatment strategies. The aim of this review is to
provide insights into the pathophysiology of cellulite
based on the available data and outcomes from
anatomical and interventional clinical studies.

Methods
A search of the PubMed database with no date
restriction was conducted in March 2019 using the
following search terms: “cellulite” AND (“physiopathology” OR “anatomy” OR “histology” OR “physiology” OR “etiology” OR “causality”). Searches were
limited to English-language publications. Reference
lists in all relevant publications were examined and used
to identify additional articles for inclusion. A search of
the ClinicalTrials.gov web site was conducted to identify clinical trials with the intention to target cellulite
(search term: “cellulite”). Using this search strategy,
206 articles were identiﬁed; of which, 65 articles were
included in this review; articles that did not quantify
cellulite severity were excluded.

Anatomy of Cellulite
The high prevalence of cellulite in women is associated
with sex-speciﬁc differences in the anatomy of the skin
and subcutaneous tissue (e.g., fat and connective tissue)1,8 and may be hormonally driven by estrogen.2
These sex-speciﬁc differences can help to increase our
understanding of cellulite pathophysiology. A 2019
anatomical study8 demonstrated that dermal thickness
is reduced with age in both men and women, suggesting that age-related changes in the dermis are not
the primary pathology in cellulite. After analyzing
thigh and buttock biopsies of 150 cadavers and 30
living women, Nürnberger and Müller1 reported that
the topographic characteristics of skin with cellulite
were caused by adipose protruding into weakened
dermal tissue. Microimaging magnetic resonance
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imaging (MRI) studies and histopathologic analysis
(n = 10, posterolateral thigh) have shown no correlation between cellulite severity and adipose layer
thickness,7 and no anatomical differences (n = 60,
buttocks, abdomen, upper thigh; n = 30 buttocks)
between subcutaneous adipose tissue when comparing
the morphology of control skin with subcutaneous fat
from cellulite.7,9–11 However, MRI and anatomical
studies have demonstrated that adipose cell chambers
in women are larger in height and width compared
with men, which may allow adipose cells to protrude
into the overlying skin.1,7,8
Differences in the number, thickness, orientation, and
interrelatedness of septae in cellulite skin have been
identiﬁed.1,6–9 Based on pathology studies, the septae of
men are oriented at 45° angles to the skin in a crisscrossing pattern, whereas women have septae that are
oriented perpendicularly to the skin.1,6–9 A biopsy study
of cellulite reported in 2000 that there was uneven
thickness of the septae across samples and that the
septae were ﬁbrosclerotic.12 Authors concluded that fat
protrusion into the dermis was a secondary event—the
result of continuous and progressive tension placed on
the septae, creating dimples and depressions characteristic of cellulite.12 Additionally, an MRI study in 30
women reported a signiﬁcant increase in the mean (SD)
thickness of septae in skin with cellulite (2.2 [0.9])
versus noncellulite skin (0.3 [0.6]; p < .001) of the
buttocks; however, there was no relationship between
septae thickness and cellulite severity.9 A 2019 anatomical study of the buttocks from cadavers of 10 men
and 10 women demonstrated that the number and type
of septae play a key role in the development of cellulite,
and the force needed to break the septae in men was
signiﬁcantly greater than in women (p = .02).8

Treatment of Cellulite
Topical Creams
Methylxanthines (e.g., caffeine) penetrate the skin to
act directly on adipose cells, promoting lipolysis,13 and
retinol can prevent in vitro human preadipocyte differentiation.14 Small clinical studies (6 studies; n = 212
women)15–20 of topical caffeine (0.1%–13.0%), retinol, or a combination of both, using varying regimens,
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reported signiﬁcant improvement in cellulite severity
(See Supplemental Digital Content 1, Table S1, http://
links.lww.com/DSS/A299).15–45 One study assessing
durability noted that cellulite severity improvements
were short term (<2 weeks).17 A sugar derivative,
sulfocarrabiose, reduced lipogenesis and increased
lipolysis in vitro, and a randomized trial of 25 women
applying a 3% sulfocarrabiose cream twice per day on
the thigh for 8 weeks noted improvement in cellulite
severity using a numeric scale (range: 0, no cellulite to
10, maximum cellulite; p < .05).21
Massage
LPG Endermologie (Endo-Systems, LLC, Fort Lauderdale, FL) is a US Food and Drug
Administration–approved mechanical massage system
for cellulite treatment that uses positive pressure from 2
rollers and negative pressure from aspiration to the skin
and subcutaneous tissue.22,23 In 2 observational studies
of whole-body endermologie (15 sessions;
35–40 minutes per session; twice weekly), signiﬁcant
improvements from baseline (p # .02) using the Nürnberger-Müller scale were observed in both studies (See
Supplemental Digital Content 1, Table S1, http://links.
lww.com/DSS/A299).22,23 However, it is unclear from
published data how durable these effects are long term.
In clinical practice, improvements in the appearance of
cellulite from massage are thought to be short lived.

Extracorporeal Shock Wave Therapy
Extracorporeal shock wave therapy (ESWT) uses electrical energy to create mechanical disruption of targeted
tissues without cytolysis, resulting in extracellular healing
responses that create tissue regeneration changes such as
collagen remodeling and improvement of local blood
circulation from neovascularization.46–49 Shock waves can
pass through tissue and conﬁne effects to areas of differing
densities, with no substantial effect on the surrounding
tissue.46,47 Radial systems produce energy in a more dispersed form, creating more diffuse and superﬁcial tissue
effects that can nonetheless penetrate up to 25 mm, thus
reaching subcutaneous fat and connective tissue structures.50 Focused waves are typically higher energy and
penetrate more deeply into tissue.51 The mechanism of
ESWT efﬁcacy has not been completely elucidated, but

studies have indicated that potential mechanisms include
induction of the formation and remodeling of collagen,
neoelastin formation, and skin laxity improvement.46,51–53
Because of effects on collagen and improvement in skin
characteristics, ESWT has been proposed as a treatment
for cellulite by targeting the dermis, adipose, and septae
(See Supplemental Digital Content 1, Table S1, http://
links.lww.com/DSS/A299).24–45,54
Clinical trials have evaluated the use of acoustic wave
therapy (AWT)26 and ESWT25,27 to target the dermis. A
randomized controlled trial of 53 women treated with
focused ESWT on the buttocks and thighs for 6 sessions
reported a signiﬁcant 2.5-point improvement (p = .001)
in photonumeric Cellulite Severity Scale (CSS)
score compared with sham control at 12 weeks
post-treatment.25 Of note, additional assessments of skin
improvement, such as change in the number (p = .01) and
depth (p = .001) of depressions in the treatment group,
were signiﬁcantly reduced versus sham control, but skin
elasticity was similar between the groups.25 A second
randomized controlled trial of 16 women treated with
radial AWT on the thighs and buttocks for 7 sessions
demonstrated statistical signiﬁcance at 1 and 3 months
post-treatment in the overall results (p = .01) of skin
waviness, surface, and volume of depressions and elevations assessed by 3-dimensional (3-D) imaging.26
Using 2-dimensional (2-D) photographs, 4 investigators
reported signiﬁcant improvement in cellulite severity
using the CSS.26 A third randomized controlled clinical
trial of 14 women treated unilaterally with radial ESWT
on the posterior thigh and buttock for 8 sessions
reported a mean improvement from baseline of 0.82
cellulite grades at 4 weeks.27
Extracorporeal shock wave therapy24 also has been evaluated in clinical trials to target adipose tissue. Combined
radial and focused ESWT treatment of the outer thighs of
15 patients assessed by ultrasound demonstrated signiﬁcant reductions at 12 weeks in mean fat thickness (0.27 6
0.13 cm; p < .0001) versus untreated legs.24 This study also
reported visual improvement of cellulite that was not
statistically analyzed, and it did not use a validated scale.24
Thus, even though signiﬁcant reductions in adipose tissue
were seen at 12 weeks, it is unclear if the improvements
had any effect on cellulite severity because the results were
not statistically compared.24
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One clinical trial has evaluated AWT28 to target the
adipose and dermis, with the intention to improve cellulite appearance. A single-center study of 30 women
with moderate-to-severe cellulite (based on CSS score)
on the thighs and buttocks reported signiﬁcant
improvement in cellulite severity following 12 sessions
with combined focused and radial AWT.28 The mean
CSS score decreased from 11.1 at baseline to 9.5 at
12 weeks post-treatment (primary end point, p < .001).
Signiﬁcant improvement from baseline at 12 weeks
post-treatment was also reported for reduction in mean
subcutaneous fat thickness (p < .001).28
Radiofrequency
Electrothermal effects of radiofrequency (RF) are
generated by the impedance of electricity ﬂow through
the tissue, and the depth of penetration for multipolar
and bipolar RF is reported as approximately half the
distance between the 2 electrodes (often less than
2–4 mm); therefore, depending on the distance
between the electrodes, application can result in more
superﬁcial and subcutaneous heating.29,55,56 Monopolar and unipolar RF can achieve $2 cm depth of
penetration into the skin for subcutaneous heating.
Multipolar RF has the potential to achieve depths of
penetration ranging from <1 cm to >4 cm.55 Therapeutic effects of RF include collagen denaturation,
which can result in skin tightening (See Supplemental
Digital Content 1, Table S1, http://links.lww.
com/DSS/A299).29,57 Of note, unipolar RF has been
shown to increase the number and thickness of septae.56 Fifty women with Grade-3 (Rossi classiﬁcation)
cellulite on the buttocks were treated with bipolar RF
for 12 weekly sessions and reported improvements in
cellulite appearance by visual and photographic
assessment; however, no statistical analysis was performed at 2 months.29 One randomized controlled
study of 45 women with Grade-1 to Grade-3 cellulite
(Nürnberger-Müller scale) used ultrasound to assess
the effects of low-level tripolar RF (regimen of 8 procedures conducted every 7–8 days) for the treatment of
the posterior thigh; this study demonstrated signiﬁcant
improvement in cellulite grade (Z = 4.372, p < .001)
and reduction in the thickness of subcutaneous tissue
(Z = 4.541, p < .001) pre/post-treatment versus placebo at 4 weeks.30 Of note, signiﬁcant changes were
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reported for dermal thickness in the RF treatment
group (p = .006), and increasing echogenicity was
consistent with an increasing number of septae.30

Laser- and Light-Based Devices
Various in vitro and in vivo studies have suggested the
potential of low-level laser therapy (LLLT) to
activate a biological cascade that increases the production of collagen.58,59 In a randomized, doubleblind, sham-controlled study, thigh and buttock cellulite (Grade-2 or -3 [Nürnberger-Müller scale]) in 68
women was treated with a 532-nm LLLT device (six
30-minute treatments during a 2-week period) with a
multiarray noncontact treatment head (See Supplemental Digital Content 1, Table S1, http://links.lww.
com/DSS/A299).32 At 2 weeks post-treatment, 55.9%
of participants achieved $1 Nürnberger-Müller scale
decrease from baseline versus sham control
(p < .0001); the improvements persisted during an
additional 4 weeks of follow-up.32 Infrared light produced from a light-emitting diode ($6 h/d for 5 consecutive days each week during a 90-day period)
demonstrated no signiﬁcant cellulite improvement in 1
randomized controlled clinical trial of 25 women with
Grade-2 or Grade-3 cellulite (Nürnberger-Müller
scale).31 At higher ﬂuence than the LLLT, the nonablative, long-pulsed 1064-nm neodymium-doped
yttrium-aluminum-garnet (Nd:YAG) laser activated a
wound repair response that resulted in the stimulation
of ﬁbroblast activity and collagen reformation.60,61
In a randomized clinical trial, mild-to-moderate
improvement in cellulite severity was observed after
treatment with a long-pulsed 1064-nm Nd:YAG
laser.33
A subdermal laser technique using a 1440-nm
Nd:YAG laser combined with a side-ﬁring ﬁber and
temperature-sensing cannula can effectively treat cellulite through a combination approach.34 This
approach initiates thermal damage to adipocytes,
severing ﬁbrous septae via thermal subcision, and
targeting the dermis using the thermal energy of the
laser to stimulate an increase in collagen.34 Four
observational studies (n = 107) evaluated the efﬁcacy
of the minimally invasive 1440-nm Nd:YAG laser
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(Cellulaze; Cynosure, Westford, MA) for the treatment of cellulite.34–37 In a study of 10 women with
moderate-to-severe cellulite who received a single
treatment, signiﬁcant improvement in skin thickness
(ultrasound) and elasticity was demonstrated at 1, 3,
6, and 12 months post-treatment (1, 3, and 6 months,
p < .001; 12 months, p # .02) in the treated thigh
versus the untreated thigh; however, no signiﬁcant
improvement was seen in cellulite severity.34 In a
subsequent multicenter study of a larger participant
population (n = 57), single treatment of bilateral thighs
and/or buttocks with the 1440-nm Nd:YAG laser
resulted in signiﬁcant mean improvement from baseline in both dimples and contour scores (5-point
scales), as observed via digital photography, at
2 months (dimple: 1.4, p < .001; contour: 1.0,
p < .001), 3 months (dimple: 1.4, p < .001; contour:
0.9, p < .001), and 6 months (dimple: 1.5, p < .001;
contour: 1.1, p < .001) versus the untreated area.35
The $1-point improvement recorded at 6 months was
maintained at 12 months in 90% of the treatment sites
(46 of 51 treatment areas in 30 patients).62 A study of
15 women with Grade-2 or Grade-3 cellulite in the
thighs and buttocks reported signiﬁcant improvement
after a single treatment in both mean dimple appearance (0–5 scale; baseline, 2.2; 6 months, 1.2; p < .005)
and mean contour irregularities (0–5 scale; baseline,
1.9; 6 months, 1.0; p < .005) with the use of 1440-nm
Nd:YAG laser, as observed by blinded investigators
reviewing 2-D photography.36 Furthermore, 3-D
photography demonstrated that overall mean dimple
depth improved by 42% (p = .0002) and 49%
(p = .0003) at 3 and 6 months, respectively.36 Using
DermaLab Elasticity Module (Cortex Technology,
Hadsund, Denmark), 25 women with Grade-2 or
Grade-3 posterior or lateral thigh cellulite (Nürnberger-Müller scale) identiﬁed signiﬁcant improvements from baseline in skin elasticity after a single
treatment (p < .01) at 2, 3, 6, and 24 months
post-treatment with the 1440-nm Nd:YAG laser.37
Improvements in cellulite severity and dermal thickness were also reported but were not quantiﬁed.37
Liposuction
Since the 1970s, liposuction has been the standard
treatment for body contouring by removal of sub-

cutaneous adipose tissue.63 However, clinical studies
evaluating the efﬁcacy of liposuction for the treatment
of cellulite are extremely limited. In addition, several
studies that did not quantify cellulite severity as an end
point did not meet the criteria to be included in this
review. A prospective study with 72 women treated
with 20 sessions of endermologie or ultrasoundassisted liposuction reported that the liposuction
treatment group had no improvement in the reduction
of cellulite (endermologie, 50% 6 16.9; liposuction,
0%; p = .001).63 It has been suggested that subcutaneous ﬁbrosis and lipoatrophy from liposuction
may cause secondary cellulite or aggravate existing
cellulite.64 In most cases, tumescent liposuction neither
improves nor worsens cellulite.65
Subcision
One of the ﬁrst studies of manual subcision was a retrospective study of 232 women with Grade-2 or Grade-3
cellulite of the buttocks and thighs, with improvement
assessed by photographs.66 After 1 treatment session,
183 (78.9%) participants reported being satisﬁed with
the improvement, and 47 (20.3%) participants had
“reasonable results.” The improvement in cellulite
appearance was reported to be persistent (>2 years) in
9.9% (n = 23) of participants.66 However, the size of the
cohort available for evaluation at that post-treatment
interval ($2 years) and the percentage of patients
available for long-term follow-up who had persistent
improvement were unclear.66 If there was evidence of
durable improvement in 9.9% of patients at >2 years,66
then these results are consistent with historical anecdotal
experience indicating that manual subcision often has
late recurrence. Also, improvements were not quantiﬁed
according to the cellulite grading scale used to score
pretreatment cellulite severity.66 In a multicenter study of
200 women who underwent 1 procedure with a manual
subcision device for cellulite, mean improvement of 8.1
(range, 7.3–9.4) on a 10-point scale was reported at
6 months postprocedure, based on photographic evidence (See Supplemental Digital Content 1, Table S1,
http://links.lww.com/DSS/A299).38 A study of manual
subcision in 2 women evaluated anatomical changes
with MRI imaging in addition to quantifying cellulite
severity using the CSS for up to 7 months post-treatment;
MRI imaging demonstrated that baseline dimple
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location correlated with the presence of thick ﬁbrous
septae located beneath the dimple. Following manual
subcision, MRI imaging conﬁrmed the septae were no
longer present beneath the dimple at 7 months
post-treatment, and more importantly, cellulite severity
was improved.54
To improve the reproducibility of the manual
procedure, a vacuum-assisted system was introduced
to provide precise control of the procedure area and
user-selected treatment depth.3 In a randomized clinical trial, 55 women with moderate-to-severe cellulite
(CSS score) underwent a single procedure and
reported a signiﬁcant reduction in mean (SD) CSS
score of 2.1 (0.7, p < .0001) and 2.0 (0.8, p < .0001) at
the 3- and 12-month follow-up, respectively, via
blinded investigator-assessment of photographs (See
Supplemental Digital Content 1, Table S1, http://links.
lww.com/DSS/A299).39 At 3 and 12 months postprocedure, 92.7% (51/55) and 94.0% (47/50) of
participants achieved $1-point improvement in CSS
score, respectively.39 At 3 years postprocedure, the
mean (SD) reduction in CSS score from baseline
remained signiﬁcant (2.0 [1.0]; p < .0001) for 45
participants from the original study, and 91.1%
(41/45) had achieved $1-point improvement in CSS
score.40 At 5 years postprocedure, the mean reduction
in CSS score was maintained (1.8; p < .0001) by 37
participants from the original study, and 87% had
achieved $1-point improvement in CSS score.41 In a
separate study of 16 women, in addition to cellulite
improvement (CSS score), a mean improvement of
67.4% in negative volume and 58.4% in minimum
dimple height, determined by 3-D imaging 6 months
postprocedure, was reported following vacuumassisted subcision.42 In a subsequent retrospective
study of vacuum-assisted subcision, 23 women with
mild-to-moderate cellulite severity reported mean
improvement from baseline of 2.9 (buttocks) and 2.8
(thighs), based on photographic assessment (score
range, 0–4), using a limited release technique.43
Overall mean cellulite improvement from baseline was
reported as 3.1.43 Both manual and vacuum-assisted
subcision have been efﬁcacious in smoothing the skin
topography through the release of the collagen-rich
subdermal septae, although durability of this effect has
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been demonstrated only for vacuum-assisted
subcision.
Collagenase Clostridium histolyticum
In a Phase 2a, randomized, double-blind, placebocontrolled study (n = 150), women treated with collagenase Clostridium histolyticum (CCH) 0.48 mg or
0.84 mg had signiﬁcant improvement from baseline in
investigator-performed mean Global Aesthetic
Improvement Scale scores at Day 73 versus placebo
(0.9 [0.48-mg dose] and 1.1 [0.84-mg dose] vs 0.5
[placebo]; p < .05 vs placebo for both; See Supplemental Digital Content 1, Table S1, http://links.lww.
com/DSS/A299).44 A Phase 2b, randomized, doubleblind study evaluated the efﬁcacy of subcutaneous
CCH 0.84 mg in 375 adult women with moderate-tosevere cellulite of the buttocks or posterolateral
thighs.45 At Day 71, 10.6% and 44.6% of patients in
the CCH group were 2-level and 1-level composite
responders (improvement in both Clinician Reported
Photonumeric CSS and Patient Reported Photonumeric CSS), respectively, versus 1.6% and 17.9%,
respectively, for placebo (p < .001 vs placebo for
both).45

Effectiveness of Cellulite Treatments by
Target Tissue
The main premise of this review is that our understanding of cellulite pathophysiology may increase by
reviewing clinical studies that target tissues associated
with cellulite. Studies failing to show the efﬁcacy (e.g.,
inconsistent results between studies, limited, or no
results) or studies with inadequate follow-up or only
short-term durability post-treatment do not provide data
in support of applicable target tissue(s) as the etiology of
cellulite. Two studies that targeted the dermis using
focused and radial ESWT devices demonstrated statistically signiﬁcant improvements in skin characteristics
and cellulite severity.25,26 These studies are suggestive
that surface skin changes can, to some degree, mask or
improve the appearance of cellulite at the intervals
evaluated. A 532-nm LLLT device, theorized to target
skin, also demonstrated signiﬁcant improvements in
cellulite severity, but only with follow-up of a few weeks
and in combination with weight loss compared with the
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control group.32 To date, no clinical studies targeting
adipose alone have demonstrated improvement in cellulite severity. In contrast, clinical studies selectively
releasing septae through vacuum-assisted subcision or
through an enzymatic agent have demonstrated signiﬁcant improvements in cellulite severity that appear to be
potentially durable.38–40,42,44,45,54,66
Technologies that target multiple tissues also have
been used as an approach for the treatment of cellulite.
Topical creams containing various active ingredients
that target the dermis and adipose have demonstrated
statistically signiﬁcant improvements in cellulite
severity with daily application; however, the durability of these improvements after cessation of treatment
was unclear or short term (#2 weeks).15–19,21 The
durability of statistically signiﬁcant improvements
seen after treatment targeting the dermis and subcutaneous tissue with endermologie is unclear.22,23
Combined, focused, and radial AWT targeting dermis
and adipose tissue demonstrated statistical improvements in cellulite severity and reductions in adipose
tissue at 3 months.28 Low-level RF30 and subdermal
laser-based devices34–37 have also been used as an
alternative approach for the treatment of cellulite to
target the adipose, dermis, and septae. Both low-level
tripolar RF and the 1440-nm Nd:YAG laser demonstrated signiﬁcant short-term improvements in cellulite severity, with the laser treatment demonstrating
durable efﬁcacy at 12 months.30,35,62 These
approaches also demonstrated improvement in skin
characteristics.30,34,37 It is difﬁcult to determine from
these studies if one or another of the target tissues was
predominately responsible for the improvements seen,
or if a combination of small responses cumulated in a
clinically meaningful overall result. Therefore, these
combination target studies do little to support or refute
the case for a given target tissue as the principle
pathophysiological culprit in the appearance of
cellulite.
Overall, multiple clinical studies that targeted septae
alone or in combination with other tissues have
reported signiﬁcant durable ($12 months) improvements in cellulite severity.34,39–41,62,66 The successes
seen with this approach are consistent with the anatomical differences in septae between cellulite-affected

skin and normal skin that were ﬁrst documented in
19781 and conﬁrmed in subsequent biopsy and
imaging studies.1,7,9,12

Discussion and Conclusions
The etiology of cellulite still has not been fully elucidated in a single comprehensive, scientiﬁcally valid
study. Limitations of using efﬁcacy studies (See Supplemental Digital Content 1, Table S1, http://links.
lww.com/DSS/A299) to elucidate the etiology of cellulite include variations in trial protocol design and
duration, evaluation time points, treatment parameters, and end points reported, as well as variation in
photography techniques and number and training of
graders. The inability to objectively quantify the
severity of cellulite at baseline, lack of grading scale
standardization among studies, and variability in
assessing degrees of cellulite improvement are further
limitations.67
There are 2 central ﬁndings of this review: (1) the
presence of visible cellulite is associated with histologic changes in the dermis, adipose tissue, and
septae, compared with unaffected skin, and (2)
efﬁcacy with a treatment strategy that targets ﬁbrous
septae (1 of the 3 primary anatomical features of
cellulite) is evidence of a cause and effect relationship for the development of cellulite. The lack of
efﬁcacy from strategies that target adipose tissue
suggests that alterations in adipose tissue are not the
primary etiology of cellulite.24 Short-term
improvements have been demonstrated with speciﬁc
technologies intended to enhance dermal thickness
or promote skin remodeling, or a strategy that targets the dermis and adipose tissue simultaneously.
However, the lack of durable efﬁcacy suggests that
dermal or dermal/adipose changes are not the primary cause of cellulite. Young adult female skin
commonly presents with cellulite, which suggests
that aging-related changes in dermal thickness are
not the primary cause of cellulite.
Clinical data support that targeting the collagen-rich
ﬁbrous septae in cellulite dimples through mechanical,
surgical, or enzymatic approaches (with or without
concomitant treatment of dermis or adipose) is most
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likely to improve skin topography and produce
durable improvement in the appearance of cellulite.
Furthermore, a 2019 anatomical study appears to
support the importance of the number and type of
septae in the etiology of cellulite.8 Researchers are
pursuing further insights into the anatomy and physiology of cellulite, but additional clinical studies to
reﬁne existing etiology hypotheses are also needed and
can only lead to a better understanding of this common condition in women.
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